You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Updates in Sleep Medicine: What You Should Know

  • Authors: Richard Balon, MD; Anita H. Clayton, MD; Ruth M. Benca, MD, PhD; Karl Doghramji, MD
  • CME / CE Released: 12/21/2021
  • Valid for credit through: 12/21/2022
Start Activity

  • Credits Available

    Physicians - maximum of 2.00 AMA PRA Category 1 Credit(s)™

    Nurses - 2.00 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for psychiatrists, primary care physicians (PCPs), neurologists, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with neuropsychiatric conditions.

The goal of this activity is to increase clinicians' knowledge in sleep disorders and narcolepsy in psychiatric patients and how to manage them.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Role of sleep in daily function
    • Relationship between sleep disorders and psychiatric disorders
    • Recognition of symptoms associated with narcolepsy
  • Have greater competence related to
    • Selecting appropriate therapies for the management of insomnia
    • Personalizing the selection of therapies for the management of narcolepsy


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Co-Chairs

  • Richard Balon, MD

    Program Co-Chair
    Professor of Psychiatry and Anesthesiology
    Associate Chair for Education Wayne State University
    Detroit, Michigan

     

    Disclosures

    Disclosure: Richard Balon, MD, has disclosed no relevant financial relationships.

  • Anita H. Clayton, MD

    Session Co-Chair/Planning Committee
    David C. Wilson Professor and Chair Department of Psychiatry and Neurobehavioral Sciences
    Professor Clinical Obstetrics and Gynecology
    University of Virginia
    Charlottesville, Virginia

    Disclosures

    Disclosure: Anita H. Clayton, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Acadia; Alkermes; Allergan; AMAG Pharmaceuticals, Inc.; Astellas; Daré Bioscience; Fabre-Kramer; Janssen Research & Development, LLC; MindCure; Ovoca Bio plc; Palatin Technologies; PureTech Health; S1 Biopharma; Sage Therapeutics; Takeda/Lundbeck; Vella Bioscience, Inc; WCG MedAvante-ProPhase
    Received grants for clinical research from: Daré Bioscience; Endoceutics, Inc.; Janssen; Relmada Therapeutics, Inc.; Sage Therapeutics
    Owns stock, stock options, or bonds from: Euthymics; S1 Biopharma

Faculty

  • Ruth M. Benca, MD, PhD

    Professor and Chair, Department of Psychiatry
    Kate Mills Snider Geropsychiatry Outreach Professor
    Wake Forest School of Medicine
    Winston-Salem, North Carolina

    Disclosures

    Disclosure: Ruth M. Benca, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Eisai; Genomind; Idorsia; Jazz Pharmaceuticals; Merck &Co.; Sage Therapeutics; Sunovion Pharmaceuticals

  • Karl Doghramji, MD

    Professor of Psychiatry, Neurology, and Medicine
    Thomas Jefferson University
    Medical Director, Jefferson Sleep Disorders Center
    Philadelphia, Pennsylvania

    Disclosures

    Disclosure: Karl Doghramji, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Eisai; Harmony Biosciences; Idorsia; Imbrium Therapeutics; Inspire Pharmaceuticals, Inc; Jazz Pharmaceuticals; Pfizer
    Received grants for clinical research from: Harmony Biosciences; Inspire Pharmaceuticals, Inc; Jazz Pharmaceuticals
    Owns stock, stock options, or bonds from: Merck & Co.

Editor

  • Pakinam Aboulsaoud, PharmD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Pakinam Aboulsaoud, PharmD, has disclosed no relevant financial relationships.

CME, CE Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Updates in Sleep Medicine: What You Should Know

Authors: Richard Balon, MD; Anita H. Clayton, MD; Ruth M. Benca, MD, PhD; Karl Doghramji, MDFaculty and Disclosures

CME / CE Released: 12/21/2021

Valid for credit through: 12/21/2022

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Understanding the Importance of Sleep: Impact on Health and Well-Being

Join Dr. Karl Doghramji as he discusses the importance of sleep and its impact on health and well-being.
Karl Doghramji, MD

Sleep Disorders in Psychiatric Practice

Join Dr. Ruth Benca as she discusses sleep disorders in psychiatric patients.
Ruth M. Benca, MD, PhD

Narcolepsy in Psychiatric Practice: More Common Than Expected

Join Dr. Karl Doghramji as he discusses the narcolepsy in psychiatric patients.
Karl Doghramji, MD

Updates in Pharmacotherapies to Promote Sleep and the Impact on Daytime Function

Join Dr. Ruth Benca as she discusses updates in pharmacotherapies to promote sleep.
Ruth M. Benca, MD, PhD
 

Pre-Assessment Survey